Clinical Trial Environmental Impact
CMC Ontology
Data FAIRy Bioassay Annotation
Global Substance Registration System
IDMP Ontology
In Vitro NAM Data Standards
In Vitro Pharmacology
Large Language Models in Life Sciences
NLP Use Case Database
Pharma General Ontology
Pharmacovigilance Systems and Processes Standards
Social Media Real World Evidence
Current Projects
Delivered Projects
AI / ML
Change Management
CSCS
Data Governance
FAIR
Future Labs Evolution
Microbiome-Mediated Drug Metabolism Database
Quantum Computing
UXLS
Current Communities
Delivered Communities
Collaboration That Delivered
New Ideas
Username or Email Address
Password
Remember Me
Webinar
There is an increasing number of reports discussing the urgent need for addressing bias in decision-making algorithms in healthcare. In this webinar industry experts will share lessons learned and discuss possible solutions.
The shortage of women in STEM is well documented. Just a quarter of the STEM workforce are women, yet research shows that diverse teams are more productive. In this fireside chat, our expert panel of speakers examine the biggest barriers for women embarking on a STEM career and discuss the importance of workplace culture and having female role models.
The FAIR Data Principles are a hot topic in research data management. Everybody wants to play FAIR, but how can principles become best practices? This webinar discusses the production and use of research data that is Findable, Accessible, Interoperable, and Reusable (FAIR) and what it means for the research ecosystem.
In this discussion, the UXLS project unveils the first draft of the Data and UX heuristics which have been crafted to support UX designers working on data-driven projects.
In 2020, a team of scientists from AstraZeneca, Bristol Myers Squibb, Novartis, and Roche set forth to find a way to convert unstructured biological assay descriptions into FAIR information objects.
Roche, as a leading biopharmaceutical company, has a diverse and distributed ecosystem of platforms to manage reference data standards used at different parts of the organization. Lynx is a FAIR-fueled system to enable seamless access across that ecosystem.
This presentation will provide practical recommendations on how to put the tsunami of RWE and data variety to work using the IMPACT framework.
Imaging biomarkers are an ideal method for drawing evidence from retrospective data and can be used both as inclusion criteria, to select relevant cohorts of patients, and as output data, to quantify responses to treatments
Blockchain technology puts patients in control of their identity and their data and has the potential to significantly change how patients are enrolled and participate in clinical trials.
Our speakers, Drs. Aleksandar Poleksic and Lei Xie, describe two new computational techniques for prediction of the differential gene expression profiles perturbed by de novo chemicals and inference of drug-disease associations.
Join us for this webinar where we will hear from a number of our project members on their approaches to scale UX in their organizations and product lines.
This webinar provided an overview of the state of play around Brexit and the impact on international pharmaceutical research.